Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation.
Seegers BA, Andriessen MP, van Hooijdonk CA, de Bakker ES, van Vlijmen-Willems IM, Parker GL, van Erp PE, van de Kerkhof PC. Seegers BA, et al. Among authors: andriessen mp. Skin Pharmacol Appl Skin Physiol. 2000 Mar-Apr;13(2):75-85. doi: 10.1159/000029911. Skin Pharmacol Appl Skin Physiol. 2000. PMID: 10754455 Clinical Trial.
Epidermal proliferation is not impaired in chronic venous ulcers.
Andriessen MP, van Bergen BH, Spruijt KI, Go IH, Schalkwijk J, van de Kerkhof PC. Andriessen MP, et al. Acta Derm Venereol. 1995 Nov;75(6):459-62. doi: 10.2340/0001555575459462. Acta Derm Venereol. 1995. PMID: 8651025 Free article.
Expression of SKALP/elafin during wound healing in human skin.
van Bergen BH, Andriessen MP, Spruijt KI, van de Kerkhof PC, Schalkwijk J. van Bergen BH, et al. Among authors: andriessen mp. Arch Dermatol Res. 1996 Jul;288(8):458-62. doi: 10.1007/BF02505235. Arch Dermatol Res. 1996. PMID: 8844125
Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE.
Zweegers J, van den Reek JM, van de Kerkhof PC, Otero ME, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Kievit W, de Jong EM. Zweegers J, et al. Among authors: andriessen mp. Br J Dermatol. 2014 Nov;171(5):1091-8. doi: 10.1111/bjd.13137. Epub 2014 Oct 20. Br J Dermatol. 2014. PMID: 24861358
Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network.
van den Reek JM, van Lüumig PP, Otero ME, Zweegers J, van de Kerkhof PC, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Seyger MM, Kievit W, de Jong EM. van den Reek JM, et al. Among authors: andriessen mp. Br J Dermatol. 2014 May;170(5):1158-65. doi: 10.1111/bjd.12862. Br J Dermatol. 2014. PMID: 24484403
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.
van den Reek JM, Zweegers J, Kievit W, Otero ME, van Lümig PP, Driessen RJ, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, van de Kerkhof PC, Seyger MM, de Jong EM. van den Reek JM, et al. Among authors: andriessen mp. Br J Dermatol. 2014 Nov;171(5):1189-96. doi: 10.1111/bjd.13087. Epub 2014 Oct 3. Br J Dermatol. 2014. PMID: 24807471
Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.
Zweegers J, Groenewoud JMM, van den Reek JMPA, Otero ME, van de Kerkhof PCM, Driessen RJB, van Lümig PPM, Njoo MD, Ossenkoppele PM, Mommers JM, Koetsier MIA, Arnold WP, Andriessen MPM, Kuijpers ALA, Berends MAM, Kievit W, de Jong EMGJ. Zweegers J, et al. Among authors: andriessen mpm. Br J Dermatol. 2017 Apr;176(4):1001-1009. doi: 10.1111/bjd.15023. Epub 2017 Mar 10. Br J Dermatol. 2017. PMID: 27579864
26 results